Position in JNJ
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$25,709,891
+$1,377,112 QoQ
Shares Held
101,232
+1.7% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.70%
of 13F equity value
Holder Rank
#649
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026RITHOLTZ WEALTH MANAGEMENT holds $147,518,356 across 14 Drug Manufacturers - General names. JNJ ranks #2 (17.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
22,420 | $26,891,222 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
101,232 | $25,709,891 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
135,292 | $17,092,791 | |
| 4 | NVS |
Novartis AG
|
105,819 | $16,583,953 | |
| 5 | ABBV |
AbbVie Inc.
|
49,487 | $12,452,908 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
169,475 | $9,765,149 | |
| 7 | BIIB |
Biogen Inc.
|
34,283 | $7,407,184 | |
| 8 | AZN |
Astrazeneca PLC
|
34,429 | $6,528,426 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,709,891 | 101,232 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $24,332,779 | 99,545 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $19,128,181 | 92,429 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $15,645,739 | 84,380 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $11,125,240 | 72,833 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $12,404,666 | 74,799 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $8,374,654 | 57,908 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $10,257,587 | 63,295 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $8,100,187 | 55,420 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $5,988,757 | 37,858 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $5,071,792 | 32,358 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $6,447,115 | 41,394 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $3,588,473 | 21,680 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $3,076,130 | 19,846 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $13,237,974 | 74,939 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $10,765,750 | 65,902 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $4,820,284 | 27,155 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $3,893,211 | 21,967 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $3,143,411 | 18,375 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $2,643,916 | 16,371 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $2,644,900 | 16,055 | Shares | Sole | 2021-07-20 | |
| 2021-03-31 | $2,432,544 | 14,801 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $1,938,134 | 12,315 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $1,798,470 | 12,080 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $1,700,216 | 12,090 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $1,339,624 | 10,216 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||